Stem cells for flu? For me, that idea is new. Some months back there was buzz about the stem cell biotech Longeveron related to its report on early trial data on testing infusions of mesenchymal stem cells for frailty in the aged. Frailty that pops up in some aging folks can manifest in a variety […]
Stem cells for the flu? Pondering PR email, frailty data from Longeveron Read More »
Each year I make a list of predictions for the year to come for the stem cell and regenerative medicine field. Then about a year later I grade myself on how I did as that year winds down. Here’s how I did in 2016. For 2017, late in 2016 I made 20 stem cell predictions. Let’s
Grading my twenty 2017 stem cell predictions Read More »
How far will stem cell clinics go to market their non-FDA approved “treatments” that they often claim will have miraculous results? I’ve never seen anything quite as striking as what some clinics in the Seattle area are now doing. In the past, we’ve seen clinics take researchers’ pictures, quotes, or videos to use for their
Seattle clinic uses FDA commish in marketing non-FDA approved stem cells Read More »
When you think of Florida, what else crosses your mind first? Orange juice? Heat and humidity? Beaches? Disney? I don’t know if this says more about me or the state, but these days I think of stem cells. Florida and California are the two biggest hotbeds of the for-profit stem cell clinic world, each with
Sentinel Takes Investigational Deep Dive into Florida Stem Cell Clinic Soup Read More »
By Hamideh Emrani (@HamidehEmrani) This year, Dr. Harold Atkins was honored with the Till & McCulloch Award. He and Dr. Mark Freedman led a clinical trial that used stem cells to reset the immune system as a treatment strategy for Multiple Sclerosis (MS) and a few other neurodegenerative diseases, such as stiff person syndrome. You can
The California Institute for Regenerative Medicine, more widely known as CIRM, has accomplished big things over the course of its history of about a decade and sparked a great deal of innovation, but what does the future hold for our stem cell agency? CIRM has a new, respected President and CEO Maria Millan solving one
Update on CIRM’s future: will it include 2020 measure? Read More »
By Samantha Yammine When our TV stops working, it’s usually because one of the wires has come unplugged. We begrudgingly huff and puff over to the back of the TV, track down the loose culprit, plug it back in, and boom: back to Netflix. If you multiply all those wires in the back of your
I started The Niche blog in largely its current form early in 2010, and now 7+ years later we’ve hit two big milestones recently. First, about a month ago, we reached 10,000 comments made on the blog. Thanks for being involved in the discussion on the Niche blog! Second, we reached 7,000,000 total page views
Two more big milestones for The Niche blog Read More »
In a nutshell, what does all of this week’s big FDA developments on stem cells and regenerative medicine mean for stem cell clinics? There’s much to be upbeat about so overall I’d say it’s good news, but I see three significant potential problems too. Dang. The good news is that the FDA seems determined to
Deconstructing FDA Mixed Bag Approach to Stem Cell Clinics Read More »
Grad school…would you do it all over again if you could jump in a time machine? It’s hard to imagine, but it was 24 years ago that I started at UCSD as a graduate student. Think how different the world was in 1993. Now almost a quarter century later, the world of science is very
Twenty years later: would this dataholic still go to grad school? Read More »